1st Counsel – Lifestyle
Author:
Quotient Therapeutics, Inc.
Quotient Therapeutics Announces Collaboration with Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology
March 24, 2026